Operational view
SCIP, article, and compliance checks
Hexabromocyclododecane is currently surfaced as authorisation list (annex xiv) in the EU.
This page turns the imported framework rows into task prompts. It is meant to answer the operational question after the status question, especially when teams need SCIP, article, procurement, or substitution guidance.
How to use this obligations page
The obligations route should connect HBCDD to building-material and polymer workflows where legacy insulation context, authorisation review, and transition planning are more relevant than a generic SCIP-only answer.
Check Candidate List threshold and SCIP relevance
Use this when the substance may sit in articles, components, or imported goods and you need to confirm communication and SCIP workflows.
Use pathwayCheck whether current use depends on an authorisation-style pathway
REACH-facing rows should trigger a direct review of legal basis, named use, and whether internal approvals still match the imported status.
Portfolio reviewScreen affected product families and formulations
The use profile suggests this substance can appear in materials portfolios where one listing can ripple across multiple SKUs, suppliers, or component bills.
AlternativesOpen structurally nearby substances before substitution work starts
The alternatives route groups lower-pressure neighbors, regulatory peers, and same-class analogs so the team can compare candidates before a sourcing scramble.